Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib (BeyPro1)

Clinical Trial ID NCT01983124

PubWeight™ 2.93^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01983124

Top papers